DABRAFENIB for Malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5,277 adverse event reports in the FDA FAERS database where DABRAFENIB was used for Malignant melanoma.
Most Reported Side Effects for DABRAFENIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pyrexia | 3,788 | 19.6% | 352 | 1,599 |
| Death | 2,740 | 14.2% | 2,733 | 198 |
| Malignant neoplasm progression | 1,667 | 8.6% | 693 | 496 |
| Fatigue | 1,328 | 6.9% | 135 | 338 |
| Nausea | 1,300 | 6.7% | 178 | 450 |
| Chills | 1,235 | 6.4% | 90 | 419 |
| Rash | 1,078 | 5.6% | 82 | 244 |
| Vomiting | 907 | 4.7% | 122 | 445 |
| Diarrhoea | 901 | 4.7% | 103 | 357 |
| Headache | 697 | 3.6% | 69 | 228 |
| Asthenia | 667 | 3.5% | 124 | 289 |
| Malaise | 585 | 3.0% | 86 | 237 |
| Decreased appetite | 546 | 2.8% | 110 | 215 |
| Arthralgia | 539 | 2.8% | 40 | 146 |
| Product use in unapproved indication | 504 | 2.6% | 94 | 60 |
Other Indications for DABRAFENIB
Product used for unknown indication (4,430)
Metastatic malignant melanoma (3,885)
Lung neoplasm malignant (610)
Thyroid cancer (583)
Non-small cell lung cancer (557)
Neoplasm malignant (356)
Braf gene mutation (224)
Braf v600e mutation positive (213)
Malignant melanoma stage iv (197)
Brain neoplasm malignant (189)
Other Drugs Used for Malignant melanoma
NIVOLUMAB (10,599)
IPILIMUMAB (8,903)
TRAMETINIB DIMETHYL SULFOXIDE (3,841)
PEMBROLIZUMAB (3,261)
BINIMETINIB (2,613)
ENCORAFENIB (2,591)
VEMURAFENIB (2,548)
TRAMETINIB (1,448)
COBIMETINIB (1,324)
TALIMOGENE LAHERPAREPVEC (562)